Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance

612 indexed citations
published 2000

Countries where authors are citing Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance

Specialization
Citations

This map shows the geographic impact of Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance more than expected).

Fields of papers citing Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

About Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance

This paper, published in 2000, received 612 indexed citations . Written by Ariel Zisman, Odile D. Peroni, E. Dale Abel, Franck Mauvais‐Jarvis, Bradford B. Lowell, Jørgen F. P. Wojtaszewski, Michael F. Hirshman, Antti Virkamäki, Laurie J. Goodyear and C. Ronald Kahn covering the research area of Molecular Biology and Physiology. It is primarily cited by scholars working on Molecular Biology (418 citations), Physiology (285 citations) and Surgery (191 citations). Published in Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/78693.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026